Electromechanical effects of newly synthetized propafenone derivatives on isolated guinea-pig heart muscle preparations. 1996

C Studenik, and R Lemmens-Gruber, and P Heistracher, and G Ecker, and A Maxl, and W Fleischhacker
Institut für Pharmakologie und Toxikologie, Pharmaziezentrum, Vienna, Austria.

Inotropic, chronotropic and beta-adrenoceptor blocking activities of the newly synthetized propafenone derivatives 1-(2-(3-diethylamino-2-hydroxypropoxy)phenyl-3-phenyl-1-propanone hydrochloride (AM 03), 1-(2-(2-hydroxy-3-(1-piperidyl)propoxy)phenyl)-3-phenyl-1-propanone hydrochloride (AM 05), N,N-dimethyl-N-(2-hydroxy-3-(2-(3- phenylpropionyl)phenoxy)propyl)-propylammonium iodide (TH 41), N,N- diethyl-N-(2-hydroxy-3-(2-(3-phenylpropionyl)phenoxy)propyl)-methylammon ium iodide (AM 07), and N,N-diiso-propyl-N-(2-hydroxy-3-(2-(3-phenylpropionyl)phenoxy)prop yl)- methylammonium iodide (AM 09) studied in isolated, electrically stimulated papillary muscles and spontaneously beating right atria of guinea pigs. In comparison with propafenone the tertiary amines AM 03 and AM 05 showed a higher negative inotropic potency, while the quarternary amines TH 41, AM 07 and AM 09 were less effective. With regard to their negative chronotropic action, AM 03 and AM 05 were more and TH 41, AM 07 and AM 09 less potent than the parent drug. In contrast to propafenone none of its derivatives exerted beta-adrenoceptor blockade at the concentrations studied.

UI MeSH Term Description Entries
D007537 Isometric Contraction Muscular contractions characterized by increase in tension without change in length. Contraction, Isometric,Contractions, Isometric,Isometric Contractions
D008297 Male Males
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D010210 Papillary Muscles Conical muscular projections from the walls of the cardiac ventricles, attached to the cusps of the atrioventricular valves by the chordae tendineae. Muscle, Papillary,Muscles, Papillary,Papillary Muscle
D011405 Propafenone An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. Apo-Propafenone,Arythmol,Baxarytmon,Cuxafenon,Fenoprain,Jutanorm,Nistaken,Norfenon,Pintoform,Prolecofen,Propafenon AL,Propafenon Hexal,Propafenon Minden,Propafenone Hydrochloride,Propafenone Hydrochloride, (R)-Isomer,Propafenone Hydrochloride, (S)-Isomer,Propafenone, (+-)-Isomer,Propafenone, (R)-Isomer,Propafenone, (S)-Isomer,Propamerck,Rythmol,Rytmo-Puren,Rytmogenat,Rytmonorm,SA-79,Hydrochloride, Propafenone,SA 79,SA79
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D005260 Female Females
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic

Related Publications

C Studenik, and R Lemmens-Gruber, and P Heistracher, and G Ecker, and A Maxl, and W Fleischhacker
July 1995, Journal of cardiovascular pharmacology,
C Studenik, and R Lemmens-Gruber, and P Heistracher, and G Ecker, and A Maxl, and W Fleischhacker
January 1999, Biological & pharmaceutical bulletin,
C Studenik, and R Lemmens-Gruber, and P Heistracher, and G Ecker, and A Maxl, and W Fleischhacker
September 1993, Biological trace element research,
C Studenik, and R Lemmens-Gruber, and P Heistracher, and G Ecker, and A Maxl, and W Fleischhacker
February 1998, The Journal of pharmacology and experimental therapeutics,
C Studenik, and R Lemmens-Gruber, and P Heistracher, and G Ecker, and A Maxl, and W Fleischhacker
December 1985, European journal of pharmacology,
C Studenik, and R Lemmens-Gruber, and P Heistracher, and G Ecker, and A Maxl, and W Fleischhacker
September 2004, Biological & pharmaceutical bulletin,
C Studenik, and R Lemmens-Gruber, and P Heistracher, and G Ecker, and A Maxl, and W Fleischhacker
July 1999, Biological & pharmaceutical bulletin,
C Studenik, and R Lemmens-Gruber, and P Heistracher, and G Ecker, and A Maxl, and W Fleischhacker
February 1990, Farmaco (Societa chimica italiana : 1989),
C Studenik, and R Lemmens-Gruber, and P Heistracher, and G Ecker, and A Maxl, and W Fleischhacker
June 1978, European journal of pharmacology,
C Studenik, and R Lemmens-Gruber, and P Heistracher, and G Ecker, and A Maxl, and W Fleischhacker
February 1988, British journal of pharmacology,
Copied contents to your clipboard!